Immune thrombocytopenia (ITP) is a disorder that refers to improper blood-clotting and its rising prevalence suggests that a tentative 5.78% CAGR is quite possible for the global immune thrombocytopenia market during the forecast period (2020-2027) and a scaling of USD 2,300 Mn seems achievable. The disease causes a drop in platelet count which ends in bruising and bleeding. It can occur in both adults and children. The disease can get triggered by other diseases such as autoimmune diseases, medications, chronic infections, pregnancy and certain type of cancers.